Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717050 · ClinicalTrials.gov registry record · NA
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
A NA study of Breast Cancer and Stroke, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT04717050: Active NA study of Breast Cancer and Stroke, sponsored by Dana-Farber Cancer Institute.
NCT04717050 is a NA study of Breast Cancer and Stroke that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 160 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04717050, a NA study of Breast Cancer and Stroke, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about testing whether exercise will improve fitness and lessen risk factors related to heart disease, diabetes, and obesity in Latina breast cancer survivors.
Primary Outcome
Visceral adiposity (VA) measured by waist to hip ratio (WHR)
Conditions Studied
Interventions
- BEHAVIORAL Progressive combine training (PCT)
- BEHAVIORAL Attention Control (AC)
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2026-06-15 |
| Phase | NA |
What the registry record for NCT04717050 still lists
NCT04717050 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Progressive combine training (PCT) is the first listed.
NCT04717050 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04717050 about?
NCT04717050 is a clinical study titled "Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity". This study is about testing whether exercise will improve fitness and lessen risk factors related to heart disease, diabetes, and obesity in Latina breast cancer survivors.
What is the current status of trial NCT04717050?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2021-08-12. Estimated completion is 2026-06-15.
What conditions does trial NCT04717050 study?
This clinical trial studies the following conditions: Breast Cancer, Stroke, Type 2 Diabetes, Coronary Artery Disease.
What interventions are being tested in trial NCT04717050?
The interventions under investigation include: Progressive combine training (PCT) (BEHAVIORAL), Attention Control (AC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04717050?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04717050 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04717050's enrollment target sits among peer trials
160 433rd of 1224 higher than 790 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI